U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07016542) titled 'Cohort for Monitoring Patients With Venous Thromboembolic Disease' on June 04.
Brief Summary: Venous thromboembolic disease is a common pathology in the general population (1.5/1000), the prognosis of which depends in particular on the risk of recurrence. This risk depends essentially on whether the thrombotic episode was provoked or not. Thus, patients who present a thromboembolic event without any contributing factor have a high risk of recurrence, which encourages clinicians to continue anticoagulant treatment for a long time. However, anticoagulant treatment is the leading cause of hospitalization for iatrogenic causes and the l...